BIIB Financial Statements & Analysis
Complete financial statements for BIIB including income statement, balance sheet, and cash flow statement. Analyze BIIB's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
74
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
-1.6% ↓
Net Income
40.6% ↑
Gross Margin
2.5% ↑
Operating Margin
7.5% ↑
Balance Sheet
Current Ratio
-32.5% ↓
Debt to Equity
-20.0% ↑
Asset Turnover
-5.8% ↓
Cash Flow
Operating Cash Flow
85.9% ↑
Net Cash Flow
155.9% ↑
Free Cash Flow
103.6% ↑
Cash Flow to Debt
105.7% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2023 | 2024 | Change | Impact |
---|---|---|---|---|
Revenue | 9.84B | 9.68B | 1.6% | |
Gross Profit | 7.30B | 7.37B | 0.9% | |
Operating Income | 2.10B | 2.22B | 5.8% | |
Net Income | 1.16B | 1.63B | 40.6% | |
EPS | 8.02 | 11.2 | 39.7% | |
EBITDA | 2.38B | 2.83B | 19.0% | |
Gross Margin | 74.24% | 76.12% | 2.5% | |
Operating Margin | 21.32% | 22.93% | 7.5% | |
Net Income Margin | 11.81% | 16.87% | 42.9% | |
R&D Expenses | 2.46B | 2.04B | 17.1% |
Income Statement Full Table
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 9.68B | 9.84B | 10.17B | 10.98B | 13.44B |
Gross Profit | 7.37B | 7.30B | 7.90B | 8.87B | 11.64B |
Operating Income | 2.22B | 2.10B | 2.90B | 2.84B | 4.55B |
Net Income | 1.63B | 1.16B | 3.05B | 1.56B | 4.00B |
EPS | 11.2 | 8.02 | 20.97 | 10.44 | 24.86 |
EBITDA | 2.83B | 2.38B | 4.36B | 3.92B | 5.73B |
Gross Margin | 76.12% | 74.24% | 77.61% | 80.79% | 86.57% |
Operating Margin | 22.93% | 21.32% | 28.52% | 25.87% | 33.84% |
Net Income Margin | 16.87% | 11.81% | 29.95% | 14.17% | 29.76% |
R&D Expenses | 2.04B | 2.46B | 2.23B | 2.50B | 3.99B |